HighTower Advisors
LFCR icon

HighTower Advisors’s Lifecore Biomedical LFCR Stock Holding History

HighTower Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-36,636
Closed -$458K – 1609
2014
Q2 		$458K Buy
+36,636
New +$431K 0.01% 1081

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

HighTower Advisors's LFCR Position: Q3 2014 in Review

HighTower Advisors sold out of Lifecore Biomedical (LFCR) in Q3 2014, closing a stake of 36,636 shares — an estimated $458K sold.

HighTower Advisors first reported a position in LFCR in Q2 2014 and held it in 1 quarter. The position peaked at $458K in Q2 2014. 107 funds tracked by Wall St. Rank hold LFCR as of Q3 2014.

  • HighTower Advisors reported no remaining Lifecore Biomedical position as of Q3 2014 after selling out during the quarter.
  • HighTower Advisors sold 36,636 Lifecore Biomedical shares in Q3 2014, an estimated $458K.
  • HighTower Advisors first reported a position in Lifecore Biomedical in Q2 2014 and held it in 1 quarter.
  • HighTower Advisors's Lifecore Biomedical position peaked at $458K in Q2 2014.
  • 107 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2014.

Based on HighTower Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.